Verdict comes as Johnson & Johnson continues to push a $6.5 billion Baby Powder settlement proposal, which seeks to force the resolution of similar ovarian cancer lawsuits through the U.S. Bankruptcy system
Findings are certain to bolster tens of thousands of talcum powder lawsuits being pursued against Johnson & Johnson, for failing to warn women about the risk of ovarian cancer.
The third Johnson & Johnson talcum powder bankruptcy settlement comes after judges have previously rejected prior attempts to force claims through the U.S. Bankruptcy system, since the manufacturer faces no financial distress.
Plaintiffs argue that more talcum powder cancer plaintiffs are likely to die while their cases are delayed yet again by Johnson & Johnson's tactics.
An Illinois jury determined that asbestos in Johnson's Baby Powder caused a woman's death from mesothelioma, awarding her family $45 million in damages.
The verdict marks the first talcum powder ovarian cancer lawsuit to be completed since Johnson & Johnson attempted to force the settlement of all claims through the U.S. Bankruptcy system, delaying the litigation for two years.
In response to continuing concerns about the health risks linked to asbestos in talc-based products, the FDA plans to implement new regulations that will establishing testing standards.
This new delay may lead to more women dying before their talcum powder lawsuits get the opportunity to go before a jury, plaintiffs' attorneys warn.
Jury was deadlocked in the first trial over the talcum powder ovarian cancer side effects to be held since a stay was lifted when Johnson & Johnson's bankruptcy bids were rejected by the federal court system.
Settlement resolves claims brought by states over deceptive advertising practices, which failed to disclose information about health risks from Baby Powder and other talcum powder products.
